Coherus Oncology, Inc. Share Price
NASDAQ: CHRS | Micro CapCoherus Oncology, Inc. Stock Performance
Coherus Oncology, Inc. Share Price Today
As of 30 October 2026, Coherus Oncology, Inc.'s share price is $0.90. The stock opened at $1.14, compared to its previous close of $1.16. During today's trading session, Coherus Oncology, Inc.'s share price traded between $0.82 and $1.14, with an average price of $0.98. Over the past 52 weeks, the stock has recorded a high of $2.61 and a low of $0.82. In terms of performance, Coherus Oncology, Inc.'s share price has declined by 49.39% over the last six months and is down 46.21% on a year-on-year basis.
Coherus Oncology, Inc. Share Price Chart
Coherus Oncology, Inc. Quarterly Profit & Loss
All figures in USD
Coherus Oncology, Inc. Annual Profit & Loss
All figures in USD
About Coherus Oncology, Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
Coherus Oncology, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.21 | $0.88 | -26.33% |
Sep 2026 | $1.35 | $1.20 | -18.09% |
Aug 2026 | $1.42 | $1.47 | +4.27% |
Jul 2026 | $1.42 | $1.41 | +0.72% |
Jun 2026 | $1.63 | $1.40 | -12.54% |
May 2026 | $1.76 | $1.59 | -10.14% |
Apr 2026 | $1.75 | $1.77 | +4.41% |
Mar 2026 | $1.64 | $1.70 | +1.49% |
Feb 2026 | $2.16 | $1.68 | -22.09% |
Jan 2026 | $1.40 | $2.15 | +51.41% |
Dec 2025 | $1.31 | $1.42 | +4.80% |
Nov 2025 | $1.69 | $1.35 | -18.86% |